Amgen, a biotechnology company, is using OpenAI's GPT-5 to improve its research and development processes. While the details of their implementation are not publicly available, it is likely that GPT-5 is being used for tasks such as text summarization, data analysis, and predictive modeling. Amgen's use of GPT-5 suggests that the company is exploring the potential benefits of AI in accelerating its research and development efforts. --- Why it matters: This matters to researchers because it highlights a growing trend of biotechnology companies adopting AI tools to streamline their workflows and improve productivity. Source: https://openai.com/index/gpt-5-amgen